Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : German's IDT to make 10M AstraZeneca vaccine doses in 2021

04/16/2021 | 11:49am EDT

BERLIN (AP) — German vaccine-maker IDT Biologika said Friday it plans to bottle this year some 10 million doses of the coronavirus shot developed by AstraZeneca.

IDT Biologika and AstraZeneca previously announced they would expand production capacity for the British-Swedish company's vaccine at a plant in the German town of Dessau by the end of 2022.

The new agreement was made possible because a third manufacturer, Merz Pharma, relinquished the production capacity it had reserved with IDT for the second quarter.

IDT produces vaccines for several pharmaceutical companies. In March, the company announced that for three months it would make the single-dose COVID-19 shot developed by Johnson & Johnson.

Chief Executive Officer Juergen Betzing said Friday that IDT was also in talks with the developers of Russia's Sputnik V shot, which has yet to be approved for use in the European Union.

The AstraZeneca vaccine is restricted to people over 60 in Germany due to concerns over rare blood clots in some recipients. Among those who received it recently are German Chancellor Angela Merkel and President Frank-Walter Steinmeier.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about ASTRAZENECA PLC
05/15ASTRAZENECA  : Family doctors say they can answer vaccine questions, after Trude..
AQ
05/15ASTRAZENECA  : India hopes COVID-19 cases stabilising even as daily deaths stay ..
RE
05/14Taiwan tightens curbs after surge in domestic COVID-19 cases
RE
05/14ASTRAZENECA  : Experts call on Canada to use COVAX doses of AstraZeneca or give ..
AQ
05/14ASTRAZENECA  : You Want It When?! EU Sues AstraZeneca Over Vaccine Delivery Dela..
AQ
05/14ASTRAZENECA  : Angola Calls for Equity in Vaccine Distribution
AQ
05/14ASTRAZENECA  : Egypt receives second shipment of 1.77 million COVID-19 vaccines ..
AQ
05/14ASTRAZENECA  : Egypt receives second shipment of 1.77 million COVID-19 vaccines ..
AQ
05/14ASTRAZENECA  : Italy audit court rejects public funding for ReiThera COVID-19 va..
RE
05/14ASTRAZENECA  : Italy audit court rejects public funding for ReiThera COVID-19 va..
RE
More news
Financials (USD)
Sales 2021 31 426 M - -
Net income 2021 4 488 M - -
Net Debt 2021 10 883 M - -
P/E ratio 2021 32,7x
Yield 2021 2,57%
Capitalization 145 B 145 B -
EV / Sales 2021 4,98x
EV / Sales 2022 4,36x
Nbr of Employees 76 100
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 130,45 $
Last Close Price 110,83 $
Spread / Highest target 49,7%
Spread / Average Target 17,7%
Spread / Lowest Target -13,2%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC7.37%145 472
JOHNSON & JOHNSON8.16%448 257
ROCHE HOLDING AG-1.80%290 657
PFIZER, INC.8.94%224 020
ABBVIE INC.8.66%205 641
NOVARTIS AG-3.78%200 099